Evidence map›Paper›PMID 33523970›Full record

ArticleScience advances2021

Tb

Kazuki Okamoto, Teppei Ebina, Naoki Fujii, Kuniaki Konishi, Yu Sato, Tetsuhiko Kashima, Risako Nakano, Hiroyuki Hioki, Haruki Takeuchi, Junji Yumoto and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kazuki OkamotoGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-1575-6030
Teppei EbinaDepartment of Physiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-3097-0513
Naoki FujiiAGC Inc., Tokyo, Japan.ORCID 0000-0002-4047-5823
Kuniaki KonishiInstitute for Photon Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-2389-9787
Yu SatoGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-5908-9711
Tetsuhiko KashimaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-1802-6482
Risako NakanoGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-2287-9058
Hiroyuki HiokiDepartment of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-0152-7854
Haruki TakeuchiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Junji YumotoInstitute for Photon Science and Technology, The University of Tokyo, Tokyo, Japan.
Masanori MatsuzakiDepartment of Physiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-3872-4322
Yuji IkegayaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. yuji@ikegaya.jp.ORCID 0000-0003-2260-8191
The University of Tokyo · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical investigation and manipulation constitute the core of biological experiments. Here, we introduce a new borosilicate glass material that contains the rare-earth ion terbium(III) (Tb

Identifiers

PMID33523970
PMCPMC7787498
OpenAlexW3118329613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.